Skip to content

EMS & Monoclonal Antibodies

Use of Monoclonal Antibodies (mAbs) by EMS agencies in our region is ENTIRELY OPTIONAL.  mAbs reduce the risk of hospitalization and death in COVID-19 patients by 71%. These drugs take up to 2 hours to deliver to a patient via IV or subcutaneous injection. Please use this survey to indicate if your agency would CONSIDER administering mAbs.  This DOES NOT COMMIT YOU TO DO SO.
1.Name(Required.)
2.Agency(Required.)
3.Phone Number(Required.)
4.Email(Required.)
5.Would your agency be willing to CONSIDER delivering MABs at various locations within your jurisdiction?(Required.)
6.Would your agency CONSIDER administration of mAbs at locations outside your jurisdiction on a mutual aid basis?(Required.)